Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression The enrollment goal of 125 patients was met. Median age was 46 years (range, 21-65 years), ...

Coverage from the 59th Annual Meeting and Exposition of the American Society of Hematology, December 9-12, 2017. In research presented at the 59th American Society of Hematology Annual (ASH) Meeting ...

Neulasta (pegfilgrastim) is a brand-name drug that’s prescribed to treat radiation sickness and prevent certain complications of chemotherapy. Neulasta comes as an injectable solution. The dosage can ...

Gary Lyman, MD, MPH, an oncologist and hematologist, compares the uptake of filgrastim biosimlars with pegfilgrastim biosimilars. Gary Lyman, MD, MPH, is an oncologist, hematologist, and public health ...

Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. Forty-eight patients with ovarian cancer were treated with cyclophosphamide and randomized to ...

Please provide your email address to receive an email when new articles are posted on . There was a substantial uptake in the use of alternative filgrastim products, including its biosimilar ...